Author

Michael Papanicolaou

Stanford MedicineORCID 0000-0002-7998-3171Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Ansuman T. SatpathyiD· 2 shared Aaron K. McCormickiD· 1 shared Alun Vaughan-JacksoniD· 1 shared Bo Peng· 1 shared Camille L. DuraniD· 1 shared Christopher S. McGinnisiD· 1 shared David R. EntenbergiD· 1 shared Emily R. WebbiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Ansuman T. SatpathyORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintSep 18, 2026

In vivo intercellular CRISPR screens using viral proximity barcoding reveal regulators of tumor-immune interactions

Peter P. Du, Seth Kohno, Mengchen Wang…·Michael Cory Bassik

This study introduces match-seq, a method to trace cell-cell interactions in vivo using CRISPR screens, revealing genetic regulators of tumor-immune interactions.

DOI 10.64898/2026.09.16.752238

mousescRNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJan 23, 2026

FAK Inhibition Remodels the Metastatic ECM and Restores CD8+ T Cell Trafficking and Immunosurveillance

Nicole D. Barth, Bo Peng, Michael Papanicolaou…·Valerie G. Brunton

This paper shows that FAK inhibition remodels the metastatic ECM, enhancing CD8+ T cell infiltration and immunosurveillance in breast cancer.

DOI 10.64898/2026.01.21.700837

mouseproteomics

𝕏 PostBluesky